Edwin M. Posadas, MD, Author at Grand Rounds in Urology

Edwin M. Posadas, MD

Cedars-Sinai

Los Angeles, California

Edwin M. Posadas, MD, FACP, is Director of the Experimental Therapeutics Program and the Medical Director of the Center for Uro-Oncology Research Excellence (CURE) / Urologic Oncology Disease Research Group at Cedars-Sinai Medical Center. He is also an associate professor at Cedars-Sinai and a full professor at the University of California, Los Angeles. Dr. Posadas received his medical degree from Johns Hopkins and completed his residency at the University of Michigan before finishing a fellowship at the National Cancer Institute in Bethesda, Maryland.

Dr. Posadas’s clinical and research interests include the treatment of advanced prostate cancer and the biology of cancer metastasis. He is studying the mechanisms through which cancer cells in localized tumors spread to other parts of the body. Hais current research interests focus on the most aggressive subtypes of prostate cancer that spread to organs such as the liver and lungs. Dr. Posadas’s laboratory has been studying the role of circulating tumor cells (CTCs) and immune cells (ICs) as biomarkers in prostate and other cancers using novel nanotechnology platforms. Clinically, he specializes in the use of medical therapies for prostate, kidney, bladder, and testis cancer with an emphasis on integrated, trans-disciplinary care.

Disclosures:

Talks by Edwin M. Posadas, MD

Need to Know: Experience with Lutetium (Pluvicto) for Prostate Cancer Theranostics

Posted by Edwin M. Posadas, MD | Mar 2023

E. David Crawford, MD, interviews Edwin M. Posadas, MD, FACP, on his clinical experience with lutetium.

Edwin M. Posadas, MD

Cedars-Sinai

Los Angeles, California

Talks by Edwin M. Posadas, MD

Need to Know: Experience with Lutetium (Pluvicto) for Prostate Cancer Theranostics

Join the GRU Community

You have Successfully Subscribed!